All 24h 7 days

Amplia opens new front in ovarian cancer fight

smh.com.au · 2026-09-15 04:53 health

Amplia Therapeutics has finalised plans for its PRROSE phase two ovarian cancer trial, with site activation and patient recruitment targeted before year-end.

Read full article →

💱 Currencies (1 EUR =)

USD—

GBP—

JPY—

RUB—

CHF—

CNY—

PLN—

UAH—

TRY—

SEK—

NOK—

DKK—

CZK—

HUF—

RON—

BGN—

INR—

BRL—

ZAR—

KRW—

SGD—

HKD—

NZD—

MXN—

ILS—

AED—

KZT—

BYN—

GEL—

AMD—

AZN—

UZS—

MDL—

RSD—

🕐 Time Zones

🇱🇻 Riga—

🇷🇺 Moscow—

🇺🇸 New York—

🇬🇧 London—

🇩🇪 Berlin—

🇯🇵 Tokyo—

🇦🇺 Sydney—

🇦🇪 Dubai—

🇨🇳 Beijing—

🇧🇷 São Paulo—

Amplia opens new front in ovarian cancer fight

More from this country